WebOct 16, 2024 · “Manufacturing cells is not like manufacturing small molecules,” Brian Culley, CEO of Lineage Cell Therapeutics, told BioSpace. “For cell therapy products to mature into ‘real’ products that deliver on the promises of 10 years ago, they must be scalable – which drives affordability – and they must solve their purity issues.” WebMar 12, 2024 · Brian Culley – Chief Executive Officer Brandi Roberts – Chief Financial Officer Conference Call Participants Joe Pantginis – H.C. Wainwright Jason McCarthy – Maxim Group Keay Nakae – Chardan...
Lineage Cell Therapeutics Announces Change to …
WebMar 23, 2024 · Brian Culley, CEO of Lineage Cell Therapeutics, discusses developing and commercializing therapies to treat degenerative diseases and adjusting to global supply … WebMay 10, 2024 · Brian Culley - Chief Executive Officer Brandi Roberts - Chief Financial Officer Ed Wirth - Chief Medical Officer Gary Hogge - Senior Vice President of Clinical & Medical Affairs, Conference... pony full kitsch
Lineage Expanding to New Carlsbad R&D Center
WebAug 9, 2024 · Brian Culley - Chief Executive Officer Brandi Roberts - Chief Financial Officer Ed Wirth - Chief Medical Officer Gary Hogge - Senior Vice President, Clinical and Medical Affairs Conference... WebThis week we tackle cell and gene therapy for hearing loss. To help us better understand the potential of allogeneic cell therapy we asked Brian Culley, CEO of Lineage Cell … WebAug 24, 2024 · Culley previously served as Chief Executive Officer of Mast Therapeutics, Inc. (MSTX), from 2010, and was also a member of its board of directors from 2011, until Mast’s merger with Savara, Inc. (SVRA) in April 2024. Mr. shape rhymes for preschoolers